STIMULAN is a pharmaceutical-grade, synthetic calcium sulfate. The physical and chemical properties are tightly controlled through Biocomposites’ patented recrystallisation process to ensure optimum purity. Evidence has shown that STIMULAN is associated with reduced drainage rates when compared to non-synthetic calcium sulfates.

With a singular focus on developing innovative calcium compound medical devices, Biocomposites has gained a deep expertise in musculoskeletal infections, trauma, spine, foot and ankle, and sports injuries.

Our products. Our innovative calcium compound devices range from bone grafts to matrices that can be used in the presence of infection.

No unauthorised copying, reproduction, distributing or republication is allowed unless prior written permission is granted by the owner, Biocomposites Ltd. Patents granted: GB2367552, EP 1204599 B1, US 6780391, EP 2594231 B1, US 8883063, CN ZL201210466117.X, GB2496710, EP 3058899 B1, US 10390954, US 10,588,748,CN ZL201610089710.5

Single-patient expanded access (compassionate use) of Biocomposites’ products. We are leaders in the development of products for use in bone and soft tissue infection, and are actively investing in a pipeline of innovative medicinal products.

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 30 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

In rare cases, when patients don’t qualify for clinical trials and have exhausted all available medical options, we may consider providing expanded access, also called “compassionate use,” of unapproved Biocomposites’ investigational medicines.

No unauthorised copying, reproduction, distributing or republication is allowed unless prior written permission is granted by the owner, Biocomposites Ltd. Patents granted: GB2367552, EP 1204599 B1, US 6780391, EP 2594231 B1, US 8883063, CN ZL201210466117.X, GB2496710, EP 3058899 B1, US 10390954, US 10,588,748,CN ZL201610089710.5

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue.

Biocomposites Inc. 700 Military Cutoff Road, Suite 320, Wilmington, NC 28405, USA